Companies › RLMD

RELMADA THERAPEUTICS INC (RLMD)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001553643 · EDGAR filings · Updated 2026-07-28

RELMADA THERAPEUTICS INC (RLMD) has reported institutional ownership of 79.8%, with 103 institutional managers holding positions valued at $581.5M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Filings this week (1)

• 2026-07-28 — Current report (8-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-06-22 — SCHEDULE 13G filed
• 2026-06-18 — Employee-plan registration (S-8) filed
• 2026-06-09 — SCHEDULE 13G filed
• 2026-05-28 — Current report (8-K) filed
• 2026-05-13 — S-3ASR filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, RELMADA THERAPEUTICS INC has 103 institutional holders and institutional ownership of 79.8%.

Insider activity

Insiders reported 17 transactions (17 buys, 0 sells) across 4 reporting insiders, with a net reported value of $3.00M.

Data flags from SEC filings

Related companies

OMADA HEALTH INC (OMDA) · BIOAGE LABS INC (BIOA) · MEIRAGTX HLDGS PLC (MGTX) · ARVINAS INC (ARVN) · IRONWOOD PHARMACEUTICALS INC (IRWD) · BUTTERFLY NETWORK INC (BFLY)